Identifying Upside Potential In XLV
by Mike Paulenoff
September 2, 2024 • 5:54 PM EDT
On August 15, with XLV (Healthcare SPDR, ETF) approaching Mike Paulenoff's target zone (noted in an April 18th post), Mike responded to an MPTrader member's question about whether it was "time to sell and find something with more potential?"
Mike wrote: "My short answer: no, it is not yet time to sell (although I will never dissuade anyone from taking profits and from ringing the cash register). My pattern and momentum work argue that upside potential extends from 156 to 161. That said, any bout of weakness that presses and closes beneath 148 will neutralize my current outlook. Bottom Line: Unless XLV reverses this week's upmove by declining beneath 148 (down about 2.5%), the current setup projects to a minimum upside target of 156 and a maximum target of 161... Last is 152.26 (8/15/24)..."
Fast-forward to this past Wednesday August 28: XLV had climbed to a new ATH of 156.44, which pushed the price structure into the lower boundary of Mike's optimal upside target zone of 156-161.
As Mike explained to members that day, with XLV trading at 155.79, "This also means it is time to be cautious about any forthcoming weakness that breaks and sustains below 154.00, the level that triggers an initial warning signal that the post-April upleg from 138.41 to 154.66 is exhausted and vulnerable to a meaningful correction."
XLV closed last week at higher ATHs of 157.20. From the time of Mike's original post to members on April 18 at 138.46, XLV has climbed 13.5%.
What's next for XLV and the healthcare sector, in general? Login this week to join Mike and our MPTrader community for ongoing discussions about the opportunistic technical setups and fundamental inputs on healthcare as well as many individual stocks, sector ETFs, macro indices, currencies, commodities, and Bitcoin.
Mike Paulenoff is the author of MPTrader.com, a real-time diary of his technical analysis & trade alerts
on
ETFs for precious metals, energy, currencies, and an array of equity indices and sectors, including
international
markets, plus key ETF component stocks in sectors like technology, mining, and banking.
Sign up for a Free 7-day Trial!
More Top Calls From Mike
On January 2, 2026, this is what I posted about CAVA (Cava Group Casual Mediterranean Cuisine) to MPTrader members:After CAVA's meteoric climb from 29.00 in October 2023 to an ATH at 172.65 in November 2024, the stock rolled over into a relentless decline that hit its low at 43.
On the morning of April 9, 2026, this is what I posted about SMR (NuScale Power Corp) to our Discussion Room for MPTrader members:SMR (Nuscale Power Corp)-- Three views of this beleaguered, former high-flying modular nuclear power producer that has been in the grasp of a relentless six-month, 84% bear phase:-- From the perspective of my 4-hour Chart, SMR has the right look of nearing the completion of the downleg that started at the Jan. 2026 recovery rally high of 22.
On the morning of April 7, 2026, this is what I posted for MPTrader members about my interpretation of the near-term technical setup exhibited by META:My preferred technical scenario for META argues that the stock established a significant near-term low at 520.00 on 3/27/26 that resides within an August 2025 to March 2026, incomplete larger corrective process.
Thirty minutes after the opening bell on November 24, 2025, I posted the following heads-up to MPTrader members about the technical setup in META:META has the right technical look of a significant U-Turn to the upside after completing a 27% August-November correction from 796.25 (8/15/25) to 580.32 (11/21/25)... To gain more powerful upside traction, META needs to climb and sustain above nearest-term resistance at 614.70 to 616.50, which if (when) taken out, will open a higher price pathway to the 670 area to challenge the down-sloping 200 DMA... Last is 609.27...
Last Friday morning, to calm frazzled nerves amid a 1% pre-market plunge that was threatening to complete a 100% give back of the prior week's 3.